InspectIR Systems, LLC

InspectIR Systems, LLC develops portable lab solutions specializing in breath sample analysis using mass spectrometry and machine learning, targeting sectors like healthcare and law enforcement. InspectIR Systems, LLC was founded in 2018 and is headquartered in Frisco, US. The company focuses on innovative testing solutions for real-time diagnostics. John Redmond, the founder, has a history of involvement in technology and healthcare ventures.

In November 2019, InspectIR raised an undisclosed amount in SEED funding, marking their first investment round. InspectIR Systems, LLC offers portable lab solutions that analyze breath samples using advanced mass spectrometry and machine learning technology. The flagship PNY-1000 system delivers lab-quality testing in the field, achieving over 99% sensitivity for COVID-19 markers and other organic compounds. Users exhale into a tube connected to the device, allowing for rapid analysis and results in under three minutes.

Additionally, the FIDO system was developed to address the fentanyl epidemic, enabling quick drug detection while reducing risks for emergency responders. The company markets its products primarily to healthcare providers, law enforcement, and emergency response units across the United States, with potential applications in other regions. InspectIR Systems operates on a B2B model, selling its testing products directly to healthcare providers, law enforcement agencies, and emergency response units. Clients typically purchase units of the PNY-1000 system or FIDO, often alongside service contracts for ongoing support.

While specific pricing details are not available, these systems are designed to enhance operational efficiency for end-users by minimizing the time and resources needed for traditional laboratory testing. The company's revenue is supported through partnerships with public health organizations and governmental bodies, aiming to improve public health response capabilities. InspectIR Systems plans to leverage funding from its SEED round in November 2019 to enhance product development and market expansion efforts. The company aims to introduce new diagnostic products tailored to emerging health challenges, although specific launch dates are yet to be announced.

Additionally, InspectIR intends to expand its presence into new geographic markets, targeting regions facing similar health crises. These initiatives reflect the company's strategy to strengthen its product offerings and broaden its market reach.